Insiders Genmab A/S Börse Stuttgart

Equities

GE91

US3723032062

Market Closed - Börse Stuttgart Other stock markets 02:01:44 2024-07-05 EDT			After market 16:00:01
23 ^EUR	0.00%		23.5	+2.17%

06-28	Would you like some more inflation?
06-28	Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genmab A/S Announces Executive Changes	03-13	CI
Danish Biotechnology Group Genmab Names New Chief Strategy Officer	23-03-28	MT
Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023	23-03-28	CI
Avantor Names Jonathan Peacock Chairman	22-05-13	MT
Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors	22-03-29	CI
Genmab Appoints New Chief Legal Officer, Chief People Officer	22-03-01	MT
Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer	22-03-01	CI
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines	21-02-22	CI
Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman	20-03-26	CI
Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period	20-03-26	CI
Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020	20-03-10	CI
Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020	20-02-21	CI
Genmab A/S Announces Executive Changes	19-10-30	CI
Genmab A/S Announces Management Changes	19-03-11	CI
Genmab A/S Appoints Judith Klimovsky as Executive Vice President and Chief Development Officer, Effective February 13, 2017	17-02-08	CI
Genmab A/S Nominates Rolf Hoffmann to its Board of Directors	16-08-03	CI
Genmab A/S Announces Board Appointments	15-03-26	CI
Genmab A/S Elects Mats Pettersson to the Board of Directors	13-04-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab: A good start to 2024; guidance unchanged

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 01:08 pm

Protect and grow your investments with the help of our experts

Secure my Investments

fermer